C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2011
12/29/2011	US20110319282 Methods and kits for the diagnosis and the staging of colorectal cancer
12/29/2011	US20110319280 Ect2 oncogene as a therapeutic target and prognostic indicator for lung and esophageal cancer
12/29/2011	US20110319278 Encoded self-assembling chemical libraries (esachel)
12/29/2011	US20110319277 Prpk-tprkb modulators and uses thereof
12/29/2011	US20110319273 Methods of analysis of allelic imbalance
12/29/2011	US20110319272 Noninvasive Diagnosis of Fetal Aneuploidy by Sequencing
12/29/2011	US20110318834 Multiple-tumor aberrant growth genes
12/29/2011	US20110318832 Human Telomerase Catalytic Subunit
12/29/2011	US20110318821 Bioagent detection methods
12/29/2011	US20110318811 Compositions and methods of using a synthetic dnase i
12/29/2011	US20110318777 Device for metering cells, method for metering cells and also use of the device
12/29/2011	US20110318776 Method for identifying germs in a liquid medium
12/29/2011	US20110318775 Method, system and composition for optically inducing cardiomyocyte contraction
12/29/2011	US20110318774 Dual sample cartridge and method for characterizing particles in liquid
12/29/2011	US20110318773 Method to use ektacytometry to improve stored red blood cell or whole blood product utilization
12/29/2011	US20110318772 Reactive coumarin derivatives and their use in cellular analyses
12/29/2011	US20110318771 Deuterium isobaric tag reagents for quantitative analysis
12/29/2011	US20110318770 Compositions, kits and methods for determining plasmin activity
12/29/2011	US20110318769 Method and composition for targeting vicious cycles of stresses and inflammatory responses
12/29/2011	US20110318768 Method for determining sensitivity of tumor cells to tyrosine kinase inhibitor and computer program product
12/29/2011	US20110318767 Method for Measuring Plasma Glucose
12/29/2011	US20110318766 Arginine vasopressin pro-hormone as predictive biomarker for diabetes
12/29/2011	US20110318764 Method for detecting muscle degenerative diseases, and method for determining therapeutic efficacy on the diseases
12/29/2011	US20110318752 Method for improving the yeild of a polypeptide
12/29/2011	US20110318751 PUMA, A PRO-APOPTOTIC GENE, AS A NOVEL MOLECULAR BIOMARKER FOR TNFalpha-INDUCED HUMAN ISLET DAMAGE
12/29/2011	US20110318750 Methods for detecting and quantifying viable bacterial endo-spores
12/29/2011	US20110318749 Method for identifying regulatory t cells
12/29/2011	US20110318748 Modified Proteins and Methods of Making and Using Same
12/29/2011	US20110318747 Nonseparation Assay Methods
12/29/2011	US20110318746 Rapid oligo probes
12/29/2011	US20110318745 Compositions and methods for performing hybridizations with separate denaturation of the sample and probe
12/29/2011	US20110318744 Method For The Detection And Characterization Of Microorganisms On A Filter
12/29/2011	US20110318743 Methods, workflows, kits, apparatuses, and computer program media for nucleic acid sample preparation for nucleic acid sequencing
12/29/2011	US20110318742 Micro rna markers for colorectal cancer
12/29/2011	US20110318741 Biomarkers for the treatment of psoriasis
12/29/2011	US20110318740 Reduced Interference from Single Strand Binding Proteins
12/29/2011	US20110318739 Determination of the degree of dna methylation
12/29/2011	US20110318738 Identification and regulation of a novel dna demethylase system
12/29/2011	US20110318737 Real-time polymerase chain reaction detection of legionella pneumophila and differentiation from other legionella species
12/29/2011	US20110318736 Allele Amplification Bias
12/29/2011	US20110318735 Regulation of the serotonin reuptake transporter and disease
12/29/2011	US20110318734 Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing
12/29/2011	US20110318733 Test system and method for the detection of analytes
12/29/2011	US20110318732 Prediction of chemotherapeutic response via single-cell profiling of transcription site activation
12/29/2011	US20110318731 Quantitative helicase assay
12/29/2011	US20110318730 Micropatterned co-culture systems as infectious disease analysis platforms
12/29/2011	US20110318729 Rapid Bioluminescence Detection Assay
12/29/2011	US20110318728 Systems, devices, methods and kits for fluid handling
12/29/2011	US20110318727 Genetic marker for detection of human papillomavirus
12/29/2011	US20110318726 Predicting coronary artery disease and risk of cardiovascular events
12/29/2011	US20110318725 Cell culture method, cell culture device, method for counting subsject matters to be counted in container and device for counting
12/29/2011	US20110318385 Engineered botulinum neurotoxin c1 with selective substrate specificity
12/29/2011	US20110318377 Methylated TAT Polypeptides and Methods of Use Thereof
12/29/2011	US20110318371 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
12/29/2011	US20110318370 Cxcl4l1 as a biomarker of pancreatic cancer
12/29/2011	US20110318369 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
12/29/2011	US20110318367 Novel targets for treatment of hypercholesterolemia
12/29/2011	US20110318365 Methods for treatment of degenerative disease associated with apoptosis
12/29/2011	US20110318363 Specific TT virus sequences and chimeric TT virus host cell DNA molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity
12/29/2011	US20110318362 Novel card proteins involved in cell death regulation
12/29/2011	US20110318361 Anticancer Drug Comprising Inhibitor of Tmprss4
12/29/2011	US20110318355 Mutant proteins of the f protein of piv-5 and piv-2
12/29/2011	US20110318344 Tumor Treatment
12/29/2011	US20110318330 Medicinal products for the treatment of blood coagulation disorders
12/29/2011	US20110318325 Inositol Pyrophosphates Determine Exocytotic Capacity
12/29/2011	US20110318312 Rejuvenation or preservation of germ cells
12/29/2011	US20110318308 Lipocalin-type prostaglandin d2 synthase as a biomarker for lung cancer progression and prognosis
12/29/2011	US20110318304 Detection of epha3 as a marker of the presence of a solid tumor
12/29/2011	US20110318301 Il-17a/f heterologous polypeptides and therapeutic uses thereof
12/29/2011	US20110318271 Arginase Inhibitors for the Treatment of Depression
12/29/2011	US20110318270 Drug identification protocol for type 2 diabetes based on gene expression signatures
12/29/2011	US20110318264 Methods and compositions for diagnosis and treatment of cancer
12/29/2011	US20110315625 Detection of micro-organisms
12/29/2011	DE10392159B4 Biosensor, Biosensorchip und Biosensoreinrichtung Biosensor, biosensor chip and biosensor
12/29/2011	DE102010025161A1 Verfahren zum Nachweis von Ribonukleinsäuren A method for the detection of ribonucleic acids
12/29/2011	DE102010024898A1 Genexpressionsanalysen zur Charakterisierung und Identifizierung genotoxischer Verbindungen Gene expression analysis for the characterization and identification of genotoxic compounds
12/29/2011	DE102008056583B4 Verfahren und Vorrichtung zur Feststellung der Reagenzienqualität Method and apparatus for determining the quality reagents
12/29/2011	CA2841142A1 Biomarkers for non-hodgkin lymphomas and uses thereof
12/29/2011	CA2803740A1 Device for determining or studying the state of stimulation of the natural defences of plants or portions of plants
12/29/2011	CA2803677A1 Gene expression analyses for characterizing and identifying genotoxic compounds
12/29/2011	CA2803161A1 Sequence specific real-time monitoring of loop-mediated isothermal amplification (lamp)
12/29/2011	CA2802964A1 Rearranged tt virus molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity
12/29/2011	CA2802946A1 Method and device
12/29/2011	CA2802919A1 Genetic markers associated with intellectual disability
12/29/2011	CA2802738A1 Chronic lymphocytic leukemia modeled in mouse by targeted mir-29 expression
12/29/2011	CA2802065A1 Analysis of a microneutralization assay using curve-fitting constraints
12/29/2011	CA2801714A1 Sensor systems having multiple probes and electrode arrays
12/29/2011	CA2801305A1 Detection of nucleic acids and proteins
12/29/2011	CA2799970A1 Compositions and methods for enhancing resistance to northern leaf blight in maize
12/28/2011	EP2400302A1 Coagulogen raw material, process for producing same, and method and apparatus for measuring organism-derived biologically active substance using same
12/28/2011	EP2400299A1 Novel factors that promote triplet repeat expansions
12/28/2011	EP2400039A2 Bio-Disc, Bio-Driver Apparatus, And Assay Method Using the Same
12/28/2011	EP2400038A1 Methods and nucleic acid constructs for screening for compounds capable of modulating VEGF expression
12/28/2011	EP2400037A1 Compositions and methods to detect legionella pneumophila nucleic acid
12/28/2011	EP2400036A1 Gene expression markers for colorectal cancer prognosis
12/28/2011	EP2400035A1 Methods and compositions for diagnosing gastrointestinal stromal tumors
12/28/2011	EP2400034A1 Diluent for preparing analytical sample
12/28/2011	EP2400033A1 Method for determining sensitivity of tumor cells to tyrosine kinase inhibitor and computer program product
12/28/2011	EP2400032A1 An improved method for measuring microbial count
12/28/2011	EP2400031A1 Method for measuring plasma glucose

1 ... 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 ... 3003